Pharmaceuticals, Biotechnology & Life Sciences Logo

Working At Rubius Therapeutics

Zippia Score 4.1

Rubius Therapeutics overview

Realizing the Power of Red™ by engineering red blood cells to transform them into cellular medicines for enzyme deficiencies, cancer and autoimmune diseases.
The average employee at Rubius Therapeutics makes $82,460 per year. In comparison, some of its highest paying competitors, like Evelo Biosciences, BRIOTECH, and NGM BIOPHARMACEUTICALS, pay $93,161, $87,218, and $86,969, respectively.
Rubius Therapeutics is a small technology company based in Cambridge, Massachusetts with only 27 employees and an annual revenue of $5.5M.







Founded in



Cambridge, MA



Organization Type


Is This Your Company?

The team at Rubius Therapeutics

Key People
  • Joanne Protano (Executive Officer)
  • Christopher Carpenter (Executive Officer)
  • Torben Nissen (Executive Officer, Director)
  • Catherine Sohn (Director)
  • Noubar Afeyan (Director)
  • Robert Langer (Director)
  • David Epstein (Director)
  • Michael Rosenblatt (Director)
  • Roger Pomerantz (Director)
  • Francis Cuss (Director)
  • Andrew Oh (Executive Officer)

What do people say about Rubius Therapeutics

Work at Rubius Therapeutics? Share your experience anonymously.

What do you like about working for Rubius Therapeutics?

Rubius Therapeutics Rankings

Rubius Therapeutics is ranked #41 on the Best Technology Companies to Work For in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rubius Therapeutics Salaries

How much does Rubius Therapeutics pay?
The national average salary for a Rubius Therapeutics employee in the United States is $82,460 per year. Employees in the top 10 percent can make over $134,000 per year, while employees at the bottom 10 percent earn less than $50,000 per year.
Salary Score
Average Employee Earnings

Rubius Therapeutics Salaries By Job Title

The average employee at Rubius Therapeutics earns a yearly salary of $82,460 per year, but different jobs can earn drastically different salaries. Some of the job titles with high salaries at Rubius Therapeutics are Senior Architect, Military Police Officer, Information Technology Project Manager, and Staff Sergeant. A worker with the title Senior Architect salary at Rubius Therapeutics can earn an average yearly salary of $115,668. To get a better sense of the salaries at Rubius Therapeutics, other roles such as Maintenance Supervisor and Vehicle Mechanic can be considered as well. For comparison, the title Maintenance Supervisor at Rubius Therapeutics earns $28,174 per year.

Do you Work At Rubius Therapeutics?

Help us make this company more transparent.


Rubius Therapeutics Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.


$5M - $10M

Founded in


Organization type


Rubius Therapeutics Financing Rounds

Mar 1, 2018Equity
Jun 22, 2017Equity

How Would You Rate The Company Culture Of Rubius Therapeutics?

Have you worked at Rubius Therapeutics? Help other job seekers by rating Rubius Therapeutics.

Rubius Therapeutics Competitors

Competitors of Rubius Therapeutics include Evelo Biosciences, BRIOTECH Inc., and NGM BIOPHARMACEUTICALS. Employees at Evelo Biosciences earn more than most of the competition, with an average yearly salary of $93,161. The employees at BRIOTECH Inc. earn an average yearly salary of $87,218 per year, and the salaries at NGM BIOPHARMACEUTICALS average $86,969 per year.
Evelo BiosciencesBiotechnology

Avg: $93,161

BRIOTECH IncBiotechnology

Avg: $87,218


Avg: $86,969


Avg: $86,927

Sharklet TechnologiesBiotechnology

Avg: $85,990

Frequently Asked Questions about Rubius Therapeutics

How many Employees does Rubius Therapeutics have?

Rubius Therapeutics has 27 employees.

How much money does Rubius Therapeutics make?

Rubius Therapeutics generates $5.5M in revenue.

What industry is Rubius Therapeutics in?

Rubius Therapeutics is in the biotechnology industry.

What type of company is Rubius Therapeutics?

Rubius Therapeutics is a private company.

Who are Rubius Therapeutics's competitors?

Rubius Therapeutics competitors include Evelo Biosciences, Abreos Biosciences, Allena Pharmaceuticals, Jounce Therapeutics, Inc., Semma Therapeutics, Nanovis, Antria, BRIOTECH Inc., NGM BIOPHARMACEUTICALS, Medgenics, Neon Therapeutics, Provivi, Inc., Cardiac Insight Inc., Northeast Biodiesel, Innoblative Designs, Inc., Clevex, Sharklet Technologies, Inc., CONJUGON, Prime Genomics, Inc., Visterra Inc..

Who works at Rubius Therapeutics?

Joanne Protano (Executive Officer)

Christopher Carpenter (Executive Officer)

Torben Nissen (Executive Officer, Director)

Show More

Where is Rubius Therapeutics's headquarters?

Rubius Therapeutics's headquarters is in Cambridge, MA.

What is Rubius Therapeutics's website?

You can find the Rubius Therapeutics website at

Are you an executive, HR leader, or brand manager at Rubius Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Rubius Therapeutics, also known as RUBIUS THERAPEUTICS INC, Rubius Therapeutics, Rubius Therapeutics Inc and Rubius Therapeutics, Inc..

Zippia gives an in-depth look into the details of Rubius Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Rubius Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Rubius Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Rubius Therapeutics and its employees or that of Zippia.